Molecular Imaging

Swiss overcome logistical issues in clinical audits
By Edna Astbury-Ward, PhD
Clinical audits in radiation protection are proving valuable in Switzerland, but serious challenges have arisen due to the country's four official languages and diverse regional cultures.
September 26, 2024
Radiation Symbol Word Cloud Thumbnail
Targeted prostate therapy displays clinical promise
By Will Morton
An emerging radiopharmaceutical treatment seems to perform as effectively in prostate cancer patients in “real-world” settings as it did in clinical trials prior to its approval.
September 25, 2024
Benign Prostatic Hyperplasia
Microplastics reach the olfactory bulb in the human brain
By Will Morton
Researchers have detected microplastics in olfactory bulb brain tissues of eight deceased individuals, and they suggest MRI could be the next step for studying the effects of the pollutants on human health.
September 23, 2024
Olfactory Bulb Brain
Radiotracer for kidney cancer performs well in phase III trial
By Will Morton
A PET radiotracer that detects clear-cell renal cell carcinoma proved safe and highly effective in a clinical trial conducted at 36 research hospitals across nine countries.
September 13, 2024
Pet Renal Cancer 66e1e00428375 Thumbnail
Mevion, Nelco to partner on proton therapy
By AuntMinnieEurope.com staff writers
Mevion Medical Systems and Nelco Worldwide are collaborating on the faster adoption of proton therapy.
September 13, 2024
Mevion Astro 2019
PET/MRI shows promise in patients with large vessel vasculitis
By Will Morton
PET/MRI could be an invaluable tool for evaluating how patients with large vessel vasculitis respond to treatments, a new study has found.
August 30, 2024
2024 08 25 Natcomms Pet Mri Treatment Response Lvv Pugh Thumbnail
FDG-PET scans can help predict risk of dementia
By Will Morton
A normal brain F-18 FDG-PET scan can rule out the short-term risk of dementia in older patients who present with cognitive complaints.
August 21, 2024
2024 08 13 Alztherapy Fdg Pet Rules Out Ad Heyer Image
AuntMinnieEurope.com Molecular Imaging Insider
By Philip Ward
New research from Norway has shown that PET/CT can help to boost outcomes in cases of pleural mesothelioma.
August 15, 2024
PET/CT provides clarity in pleural mesothelioma cases
By Edna Astbury-Ward, PhD
Metabolic tumor volume is a relatively accurate predictor of outcomes in pleural mesothelioma treated with immunotherapy, according to a Norwegian-led PET/CT study.
August 15, 2024
2024 08 15 Mol Insider Figure 6 Social
Team Sydney reports on use of PET tracer in prostate trial
By Will Morton
A PET radiotracer that targets gastrin-releasing peptide receptors (GRPR) on prostate cancer cells has shown promise in a phase II clinical trial in Australia.
August 9, 2024
Sar Bbn
PET/MRI rules out tau protein in late-life depression
By Will Morton
A Belgian PET/MRI study has provided insights into the neurobiology of late-life depression, finding tau protein is not involved in the condition.
July 29, 2024
Tau Depressed 66a16540ee0a1
LAFOV PET/CT feasible in infants with neuroblastoma
By Will Morton
Long axial field-of-view (LAFOV) PET/CT offers shorter procedure times and avoids the need for sedation or general anesthesia when imaging young children with neuroblastoma.
July 12, 2024
3 D Rendered Pet Machine 400
Page 1 of 117
Next Page